Singapore O&G (SGX:1D8) Risk Assessment

View and export this data going back to 2015. Start your Free Trial

What is Singapore O&G Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Singapore O&G is: No Data: Cannot be evaluated.

Competitive Comparison of Singapore O&G's Risk Assessment

For the Medical Care Facilities subindustry, Singapore O&G's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Singapore O&G's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore O&G's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Singapore O&G's Risk Assessment falls into.

Singapore O&G (SGX:1D8) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Singapore O&G Risk Assessment Related Terms

Thank you for viewing the detailed overview of Singapore O&G's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Singapore O&G (SGX:1D8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore O&G Ltd (SGX:1D8) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

229 Mountbatten Road, No. 02-02 Mountbatten Square, Singapore, SGP, 398007

Website

https://www.sog.com.sg

Singapore O&G Ltd is a Singapore based group of medical practioners dedicated to women's health and wellness in the obstetrics and gynaecology field. Its areas of specialisation are pregnancy care and delivery; the female reproductive system; gynaecological and breast cancer; skin and aesthetic treatments; and other ancillary medical services. The segments of the group are Obstetrics and Gynaecology, Cancer-related, Dermatology, Paediatrics and Corporate. It generates a majority of the revenue from the Obstetrics and Gynaecology Segment which relates to general obstetrics, labour and delivery, general gynaecology and surgery, female pelvic medicine, and urogynaecology and reconstructive surgery. All the operations of the organization are carried out in Singapore.

Singapore O&G (SGX:1D8) Headlines

No Headlines